Evidence map›Paper›PMID 37794274›Full record

ArticleDermatology and therapy2023

Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms.

Ericles Andrei Bellei, André Vicente Esteves de Carvalho, Beatriz Magalhães Eng, Carla Tozato, Danilo Hamilko de Barros, Erika Yumi Tamashiro, Gleison Vieira Duarte, Rafael Toledo Rodrigues de Fátima, Renata Ferreira Magalhães, Roberto Souto da Silva and 2 more

Open access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Ericles Andrei BelleiDepartment of Data, Digital, and Innovation, Novartis, São Paulo, Brazil. ericles_bellei@hotmail.com.ORCID http://orcid.org/0000-0002-6020-6356
André Vicente Esteves de CarvalhoHospital Moinhos de Ventos de Porto Alegre, Porto Alegre, Brazil.
Beatriz Magalhães EngPatient Support Program, Novartis, São Paulo, Brazil.
Carla TozatoValue and Access Division, Novartis, São Paulo, Brazil.
Danilo Hamilko de BarrosDermatology Service, Hospital Irmandade Santa Casa de Curitiba, Curitiba, Brazil.
Erika Yumi TamashiroImmunology Franchise, Novartis, São Paulo, Brazil.
Gleison Vieira DuarteInstituto Bahiano de Imunoterapia (IBIS), Salvador, Brazil.
Rafael Toledo Rodrigues de FátimaDepartment of Data, Digital, and Innovation, Novartis, São Paulo, Brazil.
Renata Ferreira MagalhãesSchool of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil.
Roberto Souto da SilvaDepartment of Dermatology, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
Wagner Guimarães Galvão CesarHospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Felipe Garutti ThiesImmunology Franchise, Novartis, São Paulo, Brazil.
Digital Science (United States) · USHospital Alemão Oswaldo Cruz · BRHospital Moinhos de Vento · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHidradenitis suppurativa (HS) is a chronic skin condition causing considerable distress. It impacts mobility, social interaction, and quality of life. In Brazil, there is a notable gap in epidemiological data and patient experiences regarding HS.

methodsThis study, spanning 2019 to 2022, employed netnography to probe the experiences of Brazilian patients with HS. This approach gleans insights from online interactions, offering a direct view into patients' lives.

resultsNotably, the data illuminated the challenges patients face, such as difficulties in obtaining a diagnosis and the complexities involved in managing a chronic, and often debilitating, condition. Furthermore, patients' experiences with various treatments, encompassing antibiotics, biologic agents, lifestyle alterations, surgical procedures, and alternative remedies, were also examined.

conclusionBy undertaking a longitudinal analysis of patient interactions, the study aimed to offer a richer understanding of HS, from its diagnosis to its treatment. It underscores the necessity for a more patient-centered approach when managing this condition. We hope that this enhanced understanding can facilitate better care for those affected by HS.

Indexed as

Global burden of diseaseHealthcare innovationHidradenitis suppurativaPatient satisfactionQuality of lifeSocial media

Identifiers

PMID37794274
PMCPMC10613171
OpenAlexW4387343721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.